Cargando…
Safety of Ultrasonic Enhancing Agents in Patients with COVID-19
Autores principales: | Argulian, Edgar, Sud, Karan, Bohra, Chandrashekar, Vogel, Birgit, Garg, Vaani, Talebi, Soheila, Lerakis, Stamatios, Narula, Jagat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby-Year Book
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255184/ https://www.ncbi.nlm.nih.gov/pubmed/32624092 http://dx.doi.org/10.1016/j.echo.2020.04.022 |
Ejemplares similares
-
Echocardiographic Findings in Patients with COVID-19 with Significant Myocardial Injury
por: Sud, Karan, et al.
Publicado: (2020) -
Right Ventricular Dilation in Hospitalized Patients With COVID-19 Infection
por: Argulian, Edgar, et al.
Publicado: (2020) -
Impact of COVID-19 Pandemic on the Role of Cardiac Sonographers
por: Garg, Vaani P., et al.
Publicado: (2021) -
The Authors Reply:
por: Sud, Karan, et al.
Publicado: (2020) -
Echocardiographic Findings in Patients With COVID-19 With Myocardial Injury During the Omicron Variant Surge
por: Alam, Loba, et al.
Publicado: (2022)